Nykode Therapeutics ASA Cash Flow Quality Index
Nykode Therapeutics ASA cash flow quality index. Nykode Therapeutics ASA (NYKD) has a Cash Flow Quality Index of 1.91x as of December 2021. Operating cash flow of Nkr180.92 Million exceeds net income of Nkr94.90 Million, indicating high earnings quality where cash backs reported profits. See financial flexibility index of Nykode Therapeutics ASA to measure the company's free cash flow as a share of total liabilities.
Cash Flow Quality Index
Operating Cash Flow
Net Income
Data as of
Cash Flow Quality Index of Nykode Therapeutics ASA (2020–2020)
Cash flow quality index of Nykode Therapeutics ASA from 2020 to 2020. Historical Cash Flow Quality Index for Nykode Therapeutics ASA across 1 annual periods. Values consistently above 1.0x indicate high-quality earnings. Explore NYKD cash flow to debt ratio to assess how comfortably operating cash covers total debt obligations.
Nykode Therapeutics ASA Cash Flow Quality Index by Year (2020–2020)
Nykode Therapeutics ASA cash flow quality index by year from 2020 to 2020. Year-by-year earnings quality comparison for Nykode Therapeutics ASA. For the full cash flow conversion analysis, see Nykode Therapeutics ASA operating cash flow efficiency.
| Year | Quality Index | Operating CF (NOK) | Net Income | YoY Change |
|---|---|---|---|---|
| 2020 | 1.00x | Nkr180.27 Million | Nkr180.91 Million | — |